News

Dacogen was approved by the FDA on May 2, 2006 for the treatment of patients with the disorder. Results from a phase III clinical trial of Dacogen demonstrated

The data are from a study called STAR, which was performed in community-based treatment settings, evaluating more than 500 adults with schizophrenia. In the study, aripiprazole demonstrated significantly

Overall, the phase III results showed that desvenlafaxine succinate (DVS-233) significantly improved depressive symptoms in adult patients compared to placebo. In a separate study investigating QTc prolongation involving

The supplemental biologics license application (sBLA) submission is for the use of Avastin (bevacizumab) in combination with taxane chemotherapy in patients who have not previously received chemotherapy for

MitoQ (mitoquinone) is a compound based on a novel technology, targeted lipophilic cations, that transport and concentrate antioxidants into the mitochondria where they accumulate up to 1,000-fold. There

Ganfort (bimatoprost/timolol ophthalmic solution) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers

Congestive heart failure (CHF) diagnosis is the leading cause of hospitalization in the US and is responsible for more than 50,000 deaths a year. Currently, heart transplantation is

The phase IIb clinical trial commenced in October 2005 and is designed to evaluate BrachySil (32-P BioSilicon) as a potential new treatment for inoperable primary liver cancer (hepatocellular

The first study evaluated the effect of Lunesta (eszopiclone) 3mg compared to placebo in patients with rheumatoid arthritis (RA) and co-existing insomnia. In this pilot study, nightly use